Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08POF
|
|||
| Former ID |
DCL000036
|
|||
| Drug Name |
ALX-0081
|
|||
| Indication | Thrombotic thrombocytopenic purpura [ICD-11: 3B64.14; ICD-10: M31.1] | Phase 3 | [1] | |
| Thrombocytopenia [ICD-11: 3B64] | Phase 2 | [2] | ||
| Company |
Ablynx
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factor. J Cardiovasc Transl Res. 2013 Jun;6(3):355-63. | |||
| REF 3 | Clinical pipeline report, company report or official report of Ablynx | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.